St. Jude Medical Announces FDA Approval Of High-Voltage Devices With New Safety Features

St. Jude Medical, Inc., a global medical device company, recently announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds)
Source: Medical Design Online News - Category: Medical Equipment Source Type: news